Xoma reported $-1.59 in EPS Earnings Per Share for its fiscal quarter ending in September of 2024.





Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Agenus USD -0.3 0.84 Dec/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Ardelyx USD 0 0 Dec/2025
aTyr Pharma USD 0.53 0.8 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Celldex Therapeutics USD -1.22 0.21 Dec/2025
Curis USD 1.23 3.26 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Emergent BioSolutions USD -0.77 0.29 Dec/2023
Incyte USD 1.8 0.46 Dec/2025
MacroGenics USD -0.22 0.49 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
Novartis USD 1.54 0.48 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Prothena USD -0.46 0.22 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Xoma USD -1.59 2.43 Sep/2024